What is the 20,320-share in-kind distribution mentioned for CME (CME)?

The 20,320-share in-kind distribution reflects WH Trading LLC transferring CME Class A shares to William W. Hobert for no consideration. This moved shares from indirect to direct ownership and was described as exempt under Rule 16a-13 in the footnotes.

What is the purpose of the 20.531-share adjustment in the CME Form 4?

The 20.531-share adjustment corrects historical clerical errors in tracking Hobert’s balances. The footnote explains this true-up aligns the reported beneficial ownership with his actual CME shareholdings as of the Form 4 filing date.

CME Group (CME) director awarded shares and shifts LLC ownership

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Hobert William W reported acquisition or exercise transactions in this Form 4 filing.

CME Group Inc. director William W. Hobert reported routine equity compensation grants and an internal ownership reclassification, with no open‑market trades. On June 25, 2026, he received two Class A Common Stock awards: 422 shares as a fully vested annual equity grant and 645 shares issued at $225 per share in lieu of part of his cash retainer.

On May 1, 2026, WH Trading LLC made a pro‑rata, in‑kind distribution of 20,320 shares of Class A Common Stock to Hobert for no consideration, moving those shares from indirect to direct ownership. A separate 20.531‑share adjustment corrected prior clerical tracking errors so reported beneficial ownership aligns with actual holdings.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Hobert William W

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock Class A	645	$225.00	$145K
Grant/Award	Common Stock Class A	422	$225.00	$95K
Other	Common Stock Class A	20,320	$0.00	--
Other	Common Stock Class A	20,320	$0.00	--

Holdings After Transaction: Common Stock Class A — 107,583.531 shares (Direct, null); Common Stock Class A — 19,680 shares (Indirect, By Firm)

Footnotes (1)

Represents a pro-rata, in-kind distribution of Class A Common Stock by WH Trading LLC to the Reporting Person for no consideration in a transaction exempt under Rule 16a-13. The Reporting Person received 20,320 shares in his individual capacity, which are now held directly. Previously, such shares were reported as being held indirectly by the Reporting Person. Effective May 1, 2026, the Reporting Person is no longer the managing member of WH Trading LLC. As a result of his retirement, the Reporting Person no longer shares voting or dispositive power over, or holds a reportable pecuniary interest in, the shares held of record by WH Trading LLC. The amount of securities beneficially owned reported in Column 5 has been adjusted to reflect an administrative tracking true-up of 20.531 shares due to a cumulative clerical error in the calculation of historical balances. This adjustment reflects the Reporting Person's actual beneficial ownership as of the date of this filing. Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions. At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.

Key Figures

Equity grant: 422 shares Shares in lieu of cash retainer: 645 shares at $225 per share In-kind distribution: 20,320 shares +1 more

4 metrics

Equity grant 422 shares Fully vested Class A grant under CME Group Director Stock Plan on June 25, 2026

Shares in lieu of cash retainer 645 shares at $225 per share Class A shares issued instead of cash board retainer on June 25, 2026

In-kind distribution 20,320 shares Pro-rata, in-kind distribution of Class A stock from WH Trading LLC on May 1, 2026

Administrative true-up 20.531 shares Adjustment to correct cumulative clerical error in historical beneficial ownership balances

Key Terms

Rule 16a-13, pro-rata, in-kind distribution, annual equity compensation program, CME Group Director Stock Plan, +1 more

5 terms

Rule 16a-13 regulatory

"in a transaction exempt under Rule 16a-13"

pro-rata, in-kind distribution financial

"Represents a pro-rata, in-kind distribution of Class A Common Stock"

annual equity compensation program financial

"issued to the Reporting Person as part of the Issuer's annual equity compensation program"

CME Group Director Stock Plan financial

"for non-employee directors under the CME Group Director Stock Plan"

pecuniary interest financial

"no longer shares voting or dispositive power over, or holds a reportable pecuniary interest in, the shares"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/29/2026 - 04:17 PM Accepted by SEC EDGAR 06/29/2026 - 04:17 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hobert William W

(Last)

(First)

(Middle)

20 S. WACKER DRIVE

(Street)

CHICAGO

ILLINOIS

60606

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CME GROUP INC. [ CME ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock Class A	05/01/2026		J		20,320	D	⁽¹⁾	19,680	I	By Firm
Common Stock Class A	05/01/2026		J		20,320	A	⁽¹⁾	106,938.531⁽²⁾	D
Common Stock Class A	06/25/2026		A⁽³⁾		645	A	$225	107,583.531	D
Common Stock Class A	06/25/2026		A⁽⁴⁾		422	A	$225	108,005.531	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents a pro-rata, in-kind distribution of Class A Common Stock by WH Trading LLC to the Reporting Person for no consideration in a transaction exempt under Rule 16a-13. The Reporting Person received 20,320 shares in his individual capacity, which are now held directly. Previously, such shares were reported as being held indirectly by the Reporting Person. Effective May 1, 2026, the Reporting Person is no longer the managing member of WH Trading LLC. As a result of his retirement, the Reporting Person no longer shares voting or dispositive power over, or holds a reportable pecuniary interest in, the shares held of record by WH Trading LLC.

2. The amount of securities beneficially owned reported in Column 5 has been adjusted to reflect an administrative tracking true-up of 20.531 shares due to a cumulative clerical error in the calculation of historical balances. This adjustment reflects the Reporting Person's actual beneficial ownership as of the date of this filing.

3. Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

4. At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.

Remarks:

	/s/ Elizabeth Hensen, as Attorney-in-Fact for William W. Hobert	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did CME (CME) director William W. Hobert report?

William W. Hobert reported equity awards and an internal transfer of CME stock. He received 422 fully vested shares, 645 shares in lieu of cash fees, and 20,320 shares via in-kind distribution from WH Trading LLC, all involving Class A Common Stock.

Were there any open-market buys or sells in this CME Form 4 filing?

No open-market purchases or sales were reported. The filing shows equity compensation grants and a pro-rata, in-kind distribution from WH Trading LLC, plus a small administrative share-count correction, but no discretionary market trades in CME Group Class A shares.

How many CME shares did William W. Hobert receive as director compensation?

He received two equity compensation grants on June 25, 2026. One grant was 422 fully vested Class A shares under the CME Group Director Stock Plan, and another 645 shares were issued at $225 per share instead of part of his annual cash retainer.

Why is WH Trading LLC referenced in William W. Hobert’s CME holdings?

WH Trading LLC previously held CME shares reported as indirectly owned by Hobert. On May 1, 2026, it made a pro-rata, in-kind distribution of 20,320 shares to him, and after his retirement as managing member, he no longer has a reportable pecuniary interest in WH Trading LLC’s remaining shares.